Monte Jade Forum (Nov. 2013): Personalized Precision Medicine - What Does It Mean For The Cancer Patient?11/07/2013 - 11/07/2013


Monte Jade Forum (Nov. 2013): Personalized Precision Medicine - What does it mean for the cancer patient?

Event Date: Thursday, November 7, 2013

Time: 6:30PM-9:00PM

Edmund Tai, MD, Medical Director, Oncology and Hematology, Palo Alto Medical Foundation; Founder, New Hope
Marty Tenenbaum, PhD, Cancer Survivor; Founder & Chairman, Cancer Commons

·   Location: ITRI International, 2870 Zanker Rd., Suite 140, San Jose, CA95134

·   Contact Info:

·   Register: 

·   Please register in advance and pay on site

·   Member & Student $10, Non-Member$20, extra $5 for site registration

·   Light dinner, soft drink and water provided 

Despite recent advances in science and technology in the field of cancer, this killer continues to take millions of lives each year. Personalized medicine, also known as precision medicine, could mean different things to different people; molecular diagnostics, targeted therapy, genetics, genomics, other “omics” — how do these things really help a cancer patient?

As new approaches are incorporated into clinical practice, individual patients and their families also have the opportunity to learn about the specific disease they are facing and to become more proactive in managing the care. Dr. Tai will share his perspective as a practicing oncologist and medical educator, to help empower our community in the fight against cancer.

With great passion and energy as a cancer survivor and Silicon Valley entrepreneur, Dr. Tenenbaum will discuss an emerging patient-led movement that empowers each patient and their care team to get the best available knowledge for beating their cancer, and to update that knowledge in real time based on each patient’s outcome.


Speaker Bio:

Edmund Tai, MD

Dr. Tai is a leading medical oncologist, a champion of community education and patient advocacy. He is the medical director of Oncology and Hematology, at Palo Alto Medical Foundation. He has been in various leadership positions with major organizations, such as the American Cancer Society, on the frontline to fight against cancer. Recently, he championed the establishment of New Hope Chinese Cancer Care Foundation to serve Chinese cancer patients and families through service, education, research, and advocacy.

Dr. Tai received his medical education at Albert Einstein College of Medicine and completed his specialist training at Harbor University of California, Los Angeles Medical Center.


J. Marty Tenenbaum, PhD

Dr. Tenenbaum is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons and CollabRx (NASD: CRLX) to help each cancer patient obtain the best possible outcome. He is an Internet commerce pioneer and visionary, having founded EIT (1990) and CommerceNet (1994) to accelerate business use of the Internet, and later, was an officer and director of Commerce One, Webify Solutions (sold to IBM in 2006), and Medstory (sold to Microsoft in 2007). He currently serves on the boards of Efficient Finance, Patients Like Me, and the Public Library of Science (PLoS).

Dr. Tenenbaum is a fellow and former board member of the Association for the Advancement of Artificial Intelligence (AAAI), and a former consulting professor of Computer Science at Stanford. He holds B.S. and M.S. degrees in Electrical Engineering and Computer Science from MIT, and a Ph.D. from Stanford.

More Information: